Bristol-Myers Squibb Company (BMY)

BMY (NYSE:Drugs) EQUITY
$55.68
neg -0.39
-0.70%
Today's Range: 55.41 - 56.31 | BMY Avg Daily Volume: 10,206,300
Last Update: 01/19/17 - 10:12 AM EST
Volume: 630,622
YTD Performance: -4.06%
Open: $56.13
Previous Close: $56.07
52 Week Range: $49.03 - $77.12
Oustanding Shares: 1,671,229,946
Market Cap: 94,056,821,361
6-Month Chart
TheStreet Ratings Grade for BMY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 6 6 5
Moderate Buy 1 1 0 0
Hold 7 9 10 10
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 2
Mean Rec. 2.35 2.50 2.56 2.65
Latest Dividend: 0.39
Latest Dividend Yield: 2.77%
Dividend Ex-Date: 01/04/17
Price Earnings Ratio: 18.27
Price Earnings Comparisons:
BMY Sector Avg. S&P 500
18.27 28.10 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
12.03% -10.69% 3.15%
GROWTH 12 Mo 3 Yr CAGR
Revenue 4.30 -0.10 -0.02
Net Income -19.60 -0.30 -0.13
EPS -22.50 -0.20 -0.07
Earnings for BMY:
EBITDA 2.27B
Revenue 16.56B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $0.66 $0.76 $2.86 $2.95
Number of Analysts 10 3 12 12
High Estimate $0.70 $0.78 $2.90 $3.09
Low Estimate $0.59 $0.74 $2.80 $2.74
Prior Year $0.38 $0.74 $2.01 $2.86
Growth Rate (Year over Year) 74.47% 2.25% 42.21% 3.32%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

David Katz

 | Jan 8, 2017 | 2:00 PM EST
Potential acquirers include Gilead Sciences, Johnson & Johnson, Pfizer, Merck and Novartis.
RMPIA
By

David Katz

 | Jan 6, 2017 | 7:00 AM EST
Potential acquirers include Gilead Sciences, Johnson & Johnson, Pfizer, Merck and Novartis.
RMPIA
By

Bret Jensen

 | Jan 3, 2017 | 11:00 AM EST
Drug giants with money to spend and a friendlier regulatory environment should spur deals.
By

Bret Jensen

 | Dec 20, 2016 | 11:00 AM EST
Egalet, Portola Pharmaceuticals and Amicus Therapeutics hold promise for improvement.

bullishBristol-Myers upgraded at Jefferies

Dec 19, 2016 | 7:06 AM EST
BMY was upgraded to Buy, Jefferies said. $69 price target. Company has an attractive clinical pipeline, buy trades at a discount to its peers.
By

Timothy Collins

 | Dec 16, 2016 | 11:38 AM EST
A couple of quick wins, a hedge/fade that didn't work, and 2 triggers not firing.
RMPIA
By

Jim Cramer

 | Dec 9, 2016 | 2:52 PM EST
It's the most random day of the week, with stocks all over the map.
By

Timothy Collins

 | Dec 9, 2016 | 11:43 AM EST
It's finally seeing a little light and is still worth owning.

updateCiti Healthcare Conf.

Dec 7, 2016 | 7:18 AM EST
Thomson ONE
Citi Global Healthcare Conference (Day 1 of 2) - 12/07/16 - 12/08/16 New York, NY
RMPIA
By

Doug Kass

 | Dec 1, 2016 | 5:48 PM EST
The U.S. dollar weakened. The price of crude oil rallied for a second day in a row, rising $1.50 to almost $51. Gold flat, no bounce. Agricultural commodities: Wheat up $0.07, corn down $0.05, soybean unchanged, oats up $0.05. Lumber up $1. Bonds got schmeissed but traded well off the day's lows (as the 10-year yield touched 2.5%). The 10-year and long-bond yields rose by 9 basis points. The 2s/10s spread rose by another 5 basis points to 130 basis points. Muncipals were lower. Junk bonds got hit badly, despite the rise in crude oil. Blackstone / GSO Strategic Credit Fund (BGB)  rose $0.08. Banks were powerful to the upside. I reshorted at reasonably good prices in the afternoon, after covering my small rental shorts in pre-market trading earlier. Insurance stocks flew. Long Hartford Financial (HIG)  , which rose. Brokerages so strong -- Morgan Stanley (MS) and Goldman Sachs (GS) (up $7). Retail was strong led by Target (TGT) , Foot Locker (FL) , Nike (NKE) and JC Penney (JCP) (long). Autos were the "world's fair." I still have tag end short positions. I expect the upside move to get over-done short term, and I will reload on the short side. Energy stocks up, but small relative to the commodity. Old tech was clobbered. International Business Machines (IBM) , Intel (INTC) , Cisco (CSCO) (short and working nicely) and Microsoft (MSFT) got bashed along with the entire sector. Biotech was down 2%. Allergan (AGN) and Gilead Sciences (GILD) were weak. New lows Vertex Pharmaceuticals (VRX) . Spec weak again (Portula Pharmaceuticals (PTLA) , Sage (SAGE) , Intrexon (XON) , FibroGen (FGEN) , ACADIA Pharmaceuticals (ACAD)  . Big pharma hurtin' badly, once more. Merck (MRK) , Bristol-Myers Squibb (BMY) and Eli Lilly (LLY) being liquidated, much like tech. Media mixed message. Disney (DIS) lower. Ag equipment: Deere (DE) up large on an upgrade, though Caterpillar (CAT) still experiencing weak fundies. Consumer staples broadly lower. Campbell Soup (CPB) excelled on a relative basis, though. (T)FANG a source of funds. Tesla (TSLA) , Facebook (FB) , Amazon (AMZN) and Alphabet (GOOGL) a collective mess. In individual stocks: DuPont (DD) , new high. Radian (RDN) up another up 2%. Oaktree Capital (OAK) not so mighty. Apple hit. Here are some value-added contributions on the site today: 1. Jim "El Capitan" Cramer on " Not What Bulls Wanted to See ."  2. "Meet" Brett Jensen on rotation.  3. Tim "Not Judy or Phil" Collins
FIBOCALL: CSX CSX gap opening higher today, based on news. Our overshoot level @ 41.92 a...
Market is little changed as we are on the cusp of a presidential turnover.  Oil up a ...
join me after the day of trading for a webinar talking about volume, how to analyze it and...
Speculators of all sizes are holding the largest bearish position in 10-year notes that we...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.